Developing a prognostic micro-RNA signature for human cervical carcinoma.
Cervical cancer remains the third most frequently diagnosed and fourth leading cause of cancer death in women worldwide. We sought to develop a micro-RNA signature that was prognostic for disease-free survival, which could potentially allow tailoring of treatment for cervical cancer patients. A cand...
Main Authors: | Christine How, Melania Pintilie, Jeff P Bruce, Angela B Y Hui, Blaise A Clarke, Philip Wong, Shaoming Yin, Rui Yan, Daryl Waggott, Paul C Boutros, Anthony Fyles, David W Hedley, Richard P Hill, Michael Milosevic, Fei-Fei Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4399941?pdf=render |
Similar Items
-
MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer.
by: Christine How, et al.
Published: (2013-01-01) -
The predictive value of nadir neutrophil count during treatment of cervical cancer: Interactions with tumor hypoxia and interstitial fluid pressure (IFP)
by: Rachel Glicksman, et al.
Published: (2017-10-01) -
Characterization of the Tumor-Microenvironment in Patient-Derived Cervix Xenografts (OCICx)
by: Richard P. Hill, et al.
Published: (2012-08-01) -
MRI‐based radiomic signatures for pretreatment prognostication in cervical cancer
by: Kari S. Wagner‐Larsen, et al.
Published: (2023-10-01) -
Eight Aging-Related Genes Prognostic Signature for Cervical Cancer
by: Meilin Yin, et al.
Published: (2023-01-01)